Shuli Kulak

Shuli Kulak, MD, MBA obtained a medical degree, with a distinction in research, after which she went on to complete a residency in pediatrics and obtain an MBA. Her passion rests in drug development for rare diseases. Past professional experience includes starting portfolio companies in the venture space and leading the gene therapy business development efforts at BioMarin Pharmaceuticals. She also previously served as Lonza’s Head of Strategy.